Impact of bariatric surgery on type 2 diabetes

Cell Biochemistry and Biophysics

Volumn 48, Issue 2-3, 2007, Pages 97-102

  Meneghini, Luigi Fernando ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Bariatric surgery; Diabetes; Gastric banding; Gastric bypass; Glucagon like Peptide 1 (GLP 1); Impaired glucose tolerance; Weight loss

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ARTICLE; BARIATRIC SURGERY; BLOOD; GASTROPLASTY; HUMAN; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTOPERATIVE COMPLICATION; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS; GASTROPLASTY; GLUCAGON-LIKE PEPTIDE 1; HUMANS; OBESITY; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 34548321630     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-007-0020-y     Document Type: Article

References (43)

1. Hedley, A. A., Ogden, C. I., Johnson, C. L., Carroll, M. D., Curtin, L. R., & Flegal, K. M. (2004). Prevalence of overweight and obesity among us children, adolescents, and adults, 1999-2002. JAMA, 291, 2847-2850.
2. Leibson, C. L., Williamson, D. F., Melton, L. J., Palumbo, P. J., Smith, S. A., Ramson, J. E., Schilling, P. L., & Narayan, K. M. (2001). Temporal trends in BMI among adults with diabetes. Diabetes Care, 24, 1584-1589.
3. Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaaniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., & Uusitura, M. for the Finnish Diabetes Prevention Study Group (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med., 344, 1343-1350.
4. Eriksson, J., Lindstrom, J., & Tuomilehto, J (2001). Potential for the prevention of type 2 diabetes. British Medical Bulletin, 60, 183-199.
5. Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine, 346, 393-403.
6. UK Prospective Diabetes Study Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 352, 837-853.
7. The Diabetes Prevention Program Research Group (2005). Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care, 28, 888-894.
8. Saaddine, J. B., Engelgau, M. M., Beckles, G. L., Gregg, E. W., Thompson, T. J., & Venkat Narayan, K. M. (2002). A diabetes report card for the United States: Quality of care in the 1990s. Annals of Internal Medicine, 136, 565-574.
9. Koro, C. E., Bowlin, S. J., Bourgeois, N., & Fedder, D. O. (2004). Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes Diabetes Care, 27, 17-20.
10. Leibbrand, R., & Fichter, M. M. (2002). Maintenance of weight loss after obesity treatment: is continuous support necessary? Behaviour Research and Therapy, 40, 1275-1289.
11. Zimmet, P., Shaw, J., & Alberti, K. G. (2003). Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabetic Medicine, 20, 693-702.
12. NIH Conference (1991). Gastrointestinal surgery for severe obesity. Consensus development conference panel. Annals of Internal Medicine, 115, 956-961.
13. Wing, R. R., Marcus, M. D., Epstein, L. H., & Salata, R. (1987). Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care, 10, 563-566.
14. Foster, G. D., Wadden, T. A., Vogt, R. A., & Brewer, G. (1997). What is a reasonable weight loss? Patient's expectations and evaluations of obesity treatment outcomes. Journals of Consulting and Clinical Psychology, 65, 79-85.
15. Steinbrook, R. (2004). Surgery for severe obesity. The New England Journal of Medicine, 350, 1075-1079.
16. Santry, H. P., Gillen, D. L., & Lauderdale, D. S. (2005). Trends in bariatric surgical procedures. JAMA, 294, 1909-1917.
17. Schneider, B. E., & Mun, E. C. (2005). Surgical management of morbid obesity. Diabetes Care, 28, 475-480.
18. Flum, D. R., Salem, L., Broeckel Elrod, J. A., Dellinger, E. P., Cheadle, A., & Chan, L. (2005). Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA, 294, 1903-1908.
19. Zingmond, D. S., McGory, M. L., & Ko, C. Y. (2005). Hospitalization before and after bypass surgery. JAMA, 294, 1918-1924.
20. Christou, N. V., Sampalis, J. S., Liberman, M., Look, D., Auger, S., McLean, A. P. H., & MacLean, L. D. (2004). Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Annals of Surgery, 240, 416-424.
21. Narbro, K., Agren, G., Jonsson, E., Naslund, I., Sjostrom, L., & Peltonen, M. (2002). Pharmaceutical costs in obese individuals: Comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment - the SOS intervention study. Archives of Internal Medicine, 162, 2061-2069.
22. Fujioka, K. (2005). Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care, 28, 481-484.
23. Wapnick, S., & Joness, J. J. (1972). Changes in glucose tolerance and serum insulin following partial gastrectomy and intestinal resection. Gut, 13, 871-873.
24. Service, G. F., Thompson, G. B., Service, F. J., Andrews, J. C., Collazo-Clavell, M. L., & Lloyd, R. V. (2005). Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. The New England Journal of Medicine, 353, 249-254.
25. Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., Bonner-Weir, S., & Goldfine, A. B. (2005). Severe hypoglycemia post-gastric bypass requiring partial pancreatectomy: Evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia, 48, 2236-2240.
26. Miholic, J., Orskov, C., Holst, J. J., Kotzerke, J., & Meyer, H. J. (1991). Emptying of the gastric substitute, Glucagon-like Peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Digestive Diseases and Sciences, 36, 1361-1370.
27. Gebhard, B., Holst, J. J., Biegelmayer, C., & Miholic, J. (2001). Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Digestive Diseases and Sciences, 46, 1915-1923.
28. Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003). Glucagon-like Peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology, 144, 5149-5158.
29. Brubaker, P. L., & Drucker, D. J. (2004). Minireview: Glucagon-like polypeptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology, 145, 2653-2659.
30. Pories, W. J., Swanson, M. S., MacDonald, K. G., Long, S. B., Morris, P. G., Brown, B. M., Barakat, H. A., deRamon, R. A., Israel, G., & Dolezal, J. M. (1995). Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Annals of Surgery, 222, 339-352.
31. Long, S., O'Brien, K., MacDonald, K. G. Jr, Leggett-Frazier, N., Swanson, M. S., Pories, W. J., & Caro, J. F. (1994). Weight loss in severely obese subjects prevents progression of impaired glucose tolerance to type II diabetes. Diabetes Care, 17, 372-375.
32. Dixon, J. B., & O'Brien, P. E. (2002). Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care, 25, 358-363.
33. Polyzogopoulou, E. V., Kalfarentzos, F., Vagenakis, A. G., & Alexandrides, T. K. (2003). Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes, 52, 1098-1103.
34. Hickey, M. S., Pories, W. J., MacDonald, K. G., Cory, K. A., Dohm, G. L., Swanson, M. S., Israel, R. G., Barakat, H. A., Considine, R. V., Caro, J. F., & Houmard, J. A. (1998). A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Annals of Surgery, 227, 637-644.
35. Kellum, J. M., Kuemmerle, J. F., O'Dorisio, T. M., Rayford, P., Martin, D., Engle, K., Wolf, L., & Sugerman, H. J. (1990). GI hormone response to meals before and after gastric bypass and vertical banded gastroplasty. Annals of Surgery, 211, 763-771.
36. Rubino, F., & Gagner, M. (2002). Potential of surgery for curing type 2 diabetes mellitus. Annals of Surgery, 236, 554-559.
37. Faraj, M., Havel, P. J., Phelis, S., Blank, D., Sniderman, A. D., & Cianflone, K. (2003). Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. The Journal of Clinical Endocrinology and Metabolism, 88, 1594-1602.
38. Sjostrom, L., Lindroos, A. K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgreen, S., Larsson, B., Narbro, K., Sjostrom, C. D., Sullivan, M., & Wedel, H. for the SOS Study Scientific Group (2004). Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. The New England Journal of Medicine, 351, 2683-2693.
39. Ferchak, C. V., & Meneghini, L. F. (2004). Obesity, bariatric surgery and type 2 diabetes: a systematic review. Diabetes Metabolism Research and Reviews, 20, 438-445.
40. Cowan, G. S., & Buffington, C. K. (1998). Significant changes in blood pressure, glucose and lipids with gastric bypass surgery. World Journal of Surgery, 22, 987-992.
41. DeMaria, E. J., Sugarman, H. J., Kellum, J. M., Meador, J. G., & Wolfe, L. G. (2002). Results of 281 consecutive total laparo-scopic Roux-en-Y gastric bypasses to treat morbid obesity. Annals of Surgery, 235, 640-647.
42. MacDonald, K. G. Jr., Long, S. D., Swanson, M. S., Brown, B. M., Morris, P., Dohm, G. L., & Pories, W. J. (1997). The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. Gastrointestinal Surgery, 1, 213-220.
43. Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K., (2004). Bariatric surgery: A systematic review and meta-analysis. JAMA, 292, 1724-1737.